MOPP chemotherapy plus irradiation for Hodgkin's disease, stages IA TO IIIB. Long-term results of the prospective trial H72 (1972–1976, 334 patients)-Reference-Cited by-同舟云学术

MOPP chemotherapy plus irradiation for Hodgkin's disease, stages IA TO IIIB. Long-term results of the prospective trial H72 (1972–1976, 334 patients)

Published:1985-10 Issue:4 Volume:3 Page:219-231
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol. Oncol.

Author:

Andrieu Jean-Marie,Dana Max,Desprez-Curely Jean-Pierre,Jacquillat Claude,Weil Maryse

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference44 articles.

1. The changing face of Hodgkin's disease

2. Abdominal involvement at the onset of Hodgkin's disease

3. Anaveri, for the Radiother-Chemother. Coop Group for HD (1984). Radiotherapy versus chemotherapy in patients with early stage Hodgkin's disease (PS I, IIA), preliminary rapport. Proc. 2nd Internat. Conf. Malignant Lymphomas (Lugano), p. 88, Abstract No. 55.

4. , , , , (1984). Combined modality therapy (chemotherapy plus radiotherapy) in Hodgkin's disease CSIA to IIIB. Results of the H 77 trial (1977–1980). Proc. 2nd Internat. Conf. Malignant Lymphomas (Lugano), p. 47, Abstract No. 57.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hodgkin's disease, clinical stages IA to IIIB: Combined modality therapy (3 MOPP followed by curative and prophylactic radiotherapy including the spleen). Six-year results;European Journal of Haematology;2009-04-24

2. POG 8625: A Randomized Trial Comparing Chemotherapy With Chemoradiotherapy for Children and Adolescents With Stages I, IIA, IIIA1 Hodgkin Disease;Journal of Pediatric Hematology/Oncology;2006-06

3. Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extended high-dose irradiation;Blood;2004-11-01

4. Three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) or epirubicin, bleomycin, vinblastine, and methotrexate (EBVM) plus extended field radiation therapy in early and intermediate Hodgkin disease: 10-year results of a randomized trial;Blood;2004-01-01

5. Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation;British Journal of Haematology;2002-07